Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke
Stroke is the leading cause of serious long-term disability, significantly reducing mobility in almost half of the affected patients aged 65 years and older. There are currently no proven neurorestorative treatments for chronic stroke. To address the complex problem of restoring function in ischemic...
Main Authors: | Joy Q. He, Eric S. Sussman, Gary K. Steinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2020.575990/full |
Similar Items
-
Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke
by: Masahito Kawabori, et al.
Published: (2020-10-01) -
Potential Mechanisms and Perspectives in Ischemic Stroke Treatment Using Stem Cell Therapies
by: Guoyang Zhou, et al.
Published: (2021-04-01) -
Stem cell therapy in ischemic stroke: A systematic review and meta-analysis of randomized controlled trials
by: Amit Kumar, et al.
Published: (2021-01-01) -
Preconditioning Strategies to Enhance Neural Stem Cell-Based Therapy for Ischemic Stroke
by: Farah Amna Othman, et al.
Published: (2020-11-01) -
Optimizing the success of cell transplantation therapy for stroke
by: Tonya M. Bliss, et al.
Published: (2010-02-01)